Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Obstacles and expectations of rare disease patients and their families in Türkiye: ISTisNA project survey results.
Hatirnaz Ng O, Sahin I, Erbilgin Y, Ozdemir O, Yucesan E, Erturk N, Yemenici M, Akgun Dogan O, Ugur Iseri SA, Satman I, Alanay Y, Ozbek U. Hatirnaz Ng O, et al. Among authors: erbilgin y. Front Public Health. 2023 Jan 4;10:1049349. doi: 10.3389/fpubh.2022.1049349. eCollection 2022. Front Public Health. 2023. PMID: 36684907 Free PMC article.
Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.
Sayitoglu M, Haznedaroğlu IC, Hatirnaz O, Erbilgin Y, Aksu S, Koca E, Adiguzel C, Bayik M, Akalin I, Gülbas Z, Akay M, Unal A, Kaynar L, Ovali E, Yilmaz M, Yenerel M, Dagdas S, Ozet G, Ar C, Aydin Y, Soysal T, Durgun B, Ozcebe O, Tukun A, Ilhan O, Ozbek U. Sayitoglu M, et al. Among authors: erbilgin y. J Int Med Res. 2009 Jul-Aug;37(4):1018-28. doi: 10.1177/147323000903700406. J Int Med Res. 2009. PMID: 19761684 Free article. Clinical Trial.
Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
Firtina S, Sayitoglu M, Hatirnaz O, Erbilgin Y, Oztunc C, Cinar S, Yildiz I, Celkan T, Anak S, Unuvar A, Devecioglu O, Timur C, Aydogan G, Akcay A, Atay D, Turkkan E, Karaman S, Orhaner B, Sarper N, Deniz G, Ozbek U. Firtina S, et al. Among authors: erbilgin y. Leuk Res. 2012 Jan;36(1):87-92. doi: 10.1016/j.leukres.2011.07.017. Epub 2011 Aug 2. Leuk Res. 2012. PMID: 21813177
Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders.
Uz B, Tatonyan SC, Sayitoglu M, Erbilgin Y, Ng OH, Buyukasik Y, Sayinalp N, Aksu S, Goker H, Ozcebe OI, Ozbek U, Haznedaroglu IC. Uz B, et al. Among authors: erbilgin y. J Renin Angiotensin Aldosterone Syst. 2013 Dec;14(4):308-14. doi: 10.1177/1470320312464677. Epub 2012 Nov 6. J Renin Angiotensin Aldosterone Syst. 2013. PMID: 23132846 Free article.
Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia.
Ng OH, Erbilgin Y, Firtina S, Celkan T, Karakas Z, Aydogan G, Turkkan E, Yildirmak Y, Timur C, Zengin E, van Dongen JJ, Staal FJ, Ozbek U, Sayitoglu M. Ng OH, et al. Among authors: erbilgin y. Blood Cancer J. 2014 Mar 14;4(3):e192. doi: 10.1038/bcj.2014.12. Blood Cancer J. 2014. PMID: 24632884 Free PMC article.
Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.
Ongoren S, Eskazan AE, Suzan V, Savci S, Erdogan Ozunal I, Berk S, Yalniz FF, Elverdi T, Salihoglu A, Erbilgin Y, Iseri SA, Ar MC, Baslar Z, Aydin Y, Tuzuner N, Ozbek U, Soysal T. Ongoren S, et al. Among authors: erbilgin y. Hematology. 2018 May;23(4):212-220. doi: 10.1080/10245332.2017.1385193. Epub 2017 Oct 9. Hematology. 2018. PMID: 28990873 Free article. Review.
27 results